Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.58 - $8.61 $80,357 - $123,992
14,401 Added 15.14%
109,495 $713,000
Q1 2024

May 15, 2024

BUY
$8.32 - $15.45 $791,182 - $1.47 Million
95,094 New
95,094 $828,000
Q4 2023

Feb 12, 2024

BUY
$8.79 - $11.51 $856,304 - $1.12 Million
97,418 New
97,418 $1.11 Million
Q1 2023

May 12, 2023

SELL
$10.37 - $12.56 $74.3 Million - $90 Million
-7,161,939 Reduced 53.69%
6,178,438 $65 Million
Q4 2022

Feb 13, 2023

SELL
$9.9 - $12.43 $5.13 Million - $6.43 Million
-517,692 Reduced 3.74%
13,340,377 $165 Million
Q3 2022

Nov 14, 2022

SELL
$10.14 - $12.38 $10.7 Million - $13.1 Million
-1,059,885 Reduced 7.1%
13,858,069 $144 Million
Q2 2022

Aug 15, 2022

SELL
$11.05 - $12.72 $2.91 Million - $3.35 Million
-263,693 Reduced 1.74%
14,917,954 $172 Million
Q1 2022

May 16, 2022

SELL
$10.61 - $12.88 $22.5 Million - $27.3 Million
-2,118,658 Reduced 12.25%
15,181,647 $191 Million
Q4 2021

Feb 11, 2022

SELL
$10.86 - $13.95 $2.18 Million - $2.8 Million
-200,716 Reduced 1.15%
17,300,305 $202 Million
Q3 2021

Nov 15, 2021

SELL
$11.92 - $13.92 $42.8 Million - $50 Million
-3,593,630 Reduced 17.04%
17,501,021 $229 Million
Q2 2021

Aug 16, 2021

SELL
$10.16 - $13.11 $961,684 - $1.24 Million
-94,654 Reduced 0.45%
21,094,651 $271 Million
Q1 2021

May 17, 2021

SELL
$9.04 - $11.86 $3.87 Million - $5.08 Million
-428,408 Reduced 1.98%
21,189,305 $237 Million
Q4 2020

Feb 12, 2021

SELL
$9.05 - $12.2 $5.95 Million - $8.02 Million
-657,441 Reduced 2.95%
21,617,713 $246 Million
Q3 2020

Nov 16, 2020

BUY
$8.99 - $10.74 $506,092 - $604,608
56,295 Added 0.25%
22,275,154 $200 Million
Q2 2020

Aug 14, 2020

BUY
$9.14 - $11.97 $1.41 Million - $1.85 Million
154,589 Added 0.7%
22,218,859 $229 Million
Q1 2020

May 14, 2020

BUY
$8.58 - $14.01 $2.92 Million - $4.77 Million
340,598 Added 1.57%
22,064,270 $223 Million
Q4 2019

Feb 11, 2020

BUY
$8.22 - $14.0 $179 Million - $304 Million
21,723,672 New
21,723,672 $289 Million

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $616M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.